Comparing Malaria Treatments in Eastern Sudan
Author Information
Author(s): Mukhtar Ebtihal A, Gadalla Nahla B, El-zaki Salah-Eldin G, Mukhtar Izdihar, Mansour Fathi A, Babiker Ahmed, El-Sayed Badria B
Primary Institution: Tropical Medicine Research Institute, Khartoum, Sudan
Hypothesis
Is artesunate plus sulphadoxine/pyrimethamine more effective than artemether-lumefantrine for treating uncomplicated malaria in eastern Sudan?
Conclusion
Both AS/SP and AL are highly effective for treating uncomplicated falciparum malaria, with AS/SP showing slightly higher efficacy.
Supporting Evidence
- 160 patients were recruited, with 157 completing the follow-up.
- The PCR-corrected efficacy was 93.5% for AS/SP and 91.3% for AL.
- AS/SP had an adequate clinical and parasitological response of 84.4%.
Takeaway
This study looked at two malaria treatments to see which one works better. Both treatments are good, but one might be a little better than the other.
Methodology
Patients were randomly assigned to receive either AS/SP or AL and followed for 28 days to assess treatment outcomes.
Limitations
The study was conducted in an area of low seasonal malaria transmission, which may affect the generalizability of the results.
Participant Demographics
{"age_mean":{"AS/SP":"17.88","AL":"18.45"},"sex_distribution":{"AS/SP":{"female":39,"male":41},"AL":{"female":47,"male":33}}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website